TUH

5-[2,4-dihydroxy-5-(propan-2-yl)phenyl]-4-(1-methyl-1H-indol-5-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one


Toggle HydrogenToggle Labels

Chemical Component Summary

Name5-[2,4-dihydroxy-5-(propan-2-yl)phenyl]-4-(1-methyl-1H-indol-5-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one
SynonymsGanetespib
Identifiers3-[2,4-bis(oxidanyl)-5-propan-2-yl-phenyl]-4-(1-methylindol-5-yl)-1H-1,2,4-triazol-5-one
FormulaC20 H20 N4 O3
Molecular Weight364.398
TypeNON-POLYMER
Isomeric SMILESCC(C)c1cc(c(cc1O)O)C2=NNC(=O)N2c3ccc4c(c3)ccn4C
InChIInChI=1S/C20H20N4O3/c1-11(2)14-9-15(18(26)10-17(14)25)19-21-22-20(27)24(19)13-4-5-16-12(8-13)6-7-23(16)3/h4-11,25-26H,1-3H3,(H,22,27)
InChIKeyRVAQIUULWULRNW-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count47
Chiral Atom Count0
Bond Count50
Aromatic Bond Count16

Drug Info: DrugBank

DrugBank IDDB12047 
NameGanetespib
Groups investigational
DescriptionGanetespib is under investigation for the treatment of BREAST CANCER, Small Cell Lung Cancer, Acute Myeloid Leukaemia, and Myelodysplastic Syndrome.
SynonymsGanetespib
CategoriesHSP90 Heat-Shock Proteins, antagonists & inhibitors
CAS number888216-25-9

Related Resource References

Resource NameReference
Pharos CHEMBL2103879
PubChem 135564985
ChEMBL CHEMBL2103879